@BowtellLab

Understanding the Genomic Characterisation of Ovarian Cancer 🔬Cancer Genomics and Genetics @PeterMacRes @PeterMacCC @PrDavidBowtell

 Parkville, Melbourne
Joined July 2019
  • Tweets163
  • Following150
  • Followers454
6Media
Read the latest research from the Christie lab @PeterMacRes on MHCII and whole genome duplication in ovarian cancer, published with @SpringerNature in @NatureComms nature.com/articles/s41467-0…

Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous...

Nature Communications - There is high prevalence of whole genome duplication (WGD) in high grade serous ovarian cancer. Here, the authors compare tumours with and without WGD and find that those...

nature.com
3
10
3
32
2,065
This symposium is going to be amazing. Want to join our PREDICT network? Pls come along. 👇
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
5
13
1,136
Congratulations to ⁦@g_auyeung⁩ and Dr Sathya Manoharan and team from ⁦@PeterMacCC⁩ ⁦@BowtellLab⁩ on completing and presenting this investigator- initiated BEACON trial showing interesting activity of a non- chemo combo in platinum resistant ovarian cancer
1
1
1
36
719
Next in the spotlight at #IGCS2023 Dr Nikki Burdett’s work from her thesis in @DrLizChristie lab illustrating the tumour heterogeneity in HGSOC from primary to end stage disease @PMPostdocs @PeterMacRes 🔥
2
14
740
Replying to @DrDaleGarsed
@DrDaleGarsed @DrKathAlsop @BowtellLab studies of exceptional responders being highlighted by Dr Kathleen Moore at #IGCS2023 in discussion of PARPi, are they for everyone? @PMPostdocs @PeterMacRes
3
9
448
Thanks to the #IGCS2023 scientific committee for selecting our IGNITE abstract as best oral abstract! Proud to be representing @anzgog @PeterMacCC and thx to the whole study team especially @LindaMileshkin @BowtellLab for giving me the opportunity to lead the study
6
9
1
67
3,757
Prof David Bowtell @bowtelllab was honoured to give the AACR Foundation Special Conference on Ovarian Cancer opening keynote address. He shared where his lab has directed their efforts to maximise returns in #OvarianCancer #research #cancer #GynecologicalCancer
4
29
1,460
BowtellLab retweeted
ANZGOG
@anzgog8 Sep 2023
Collaboration is a necessity in ensuring a relevant, vibrant, impactful research agenda 🤝 One particular example of collaboration at ANZGOG is between scientists and clinicians, who work together to advance research 'bench to bedside' for gynaecological cancer patients.
4
20
3,964
We're so thrilled to have three incredible staff recognised at the annual @anzgog awards last night. Congratulations @LindaMileshkin, @BowtellLab and Dr Nikki Burdett! Read more: petermac.org/news/peter-mac-… | #ANZGOG2023ASM @PeterMacCC
1
2
24
1,256
BowtellLab retweeted
ANZGOG
@anzgog23 Mar 2023
Next up is the Research Pioneer Award, which recognises pioneering gynaecological cancer research. Congratulations to Prof David Bowtell, who has consistently led innovation in ovarian cancer research and is immensely deserving of this award. @BowtellLab @PeterMacRes @PeterMacCC – at Brisbane, Queensland
2
4
2
51
4,075
BowtellLab retweeted
ANZGOG
@anzgog23 Mar 2023
Congratulations to Dr Nikki Burdett for winning the Michael Friedlander AM Award 👏 This award recognises an outstanding early career researcher, one of our future leaders of ANZGOG. #ANZGOG2023ASM – at Brisbane, Queensland
1
6
1
35
2,283
BowtellLab retweeted
ANZGOG
@anzgog23 Mar 2023
Data from the EVOLVE trial highlighting the importance of looking for resistance mechanisms @DrLizChristie @BowtellLab #ovariancancer #ANZGOG2023ASM
3
10
503
BowtellLab retweeted
ANZGOG
@anzgog23 Mar 2023
Replying to @BowtellLab
@BowtellLab and #AOCS acknowledged for the fundamental contributions to understanding #ovca #HGSC biology #ANZGOG2023ASM
2
3
213
Excited to share the first publication from the Christie lab @PeterMacRes in @NatureGenet 'Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer' rdcu.be/c6uNt
21
17
6
143
14,822
Congratulations @DrLizChristie on this important new paper! #OvarianCancer Study reveals why some ovarian cancer patients become resistant to treatment abc.net.au/news/health/2023-… via @ABCaustralia

New study reveals why ovarian cancer treatment stops working in some people

A team of international researchers, led by Australian scientists, has identified why some ovarian cancers become resistant to treatment.

abc.net.au
5
17
1,397
Honoured to write this Understanding the Pathway piece for #jco Thanks to my 2 wonderful mentors @LindaMileshkin @BowtellLab for the opportunity to lead this important work and to all our collaborators @PeterMacRes @PeterMacCC @anzgog ascopubs.org/doi/abs/10.1200…

CCNE1 Amplification as a Therapeutic Target

ascopubs.org
1
4
2
43
3,540
Listen to Prof David Bowtell @BowtellLab explaining our approach @PeterMacCC @PeterMacRes to understand how some women survive ovarian cancer👇🏻
EXPeditions@joinExpeditions2 Jan 2023
Why do some people survive cancer? David Bowtell, Co-head of the Women’s Cancer Program at the Peter MacCallum Cancer Centre, has been studying ovarian cancer patients who have beaten the odds. #OvarianCancer #CancerSurvivors @PeterMacCC bit.ly/35PGlhY
4
2
898
Replying to @DrDaleGarsed @BowtellLab @theage
It has been wonderful to collaborate with Bronwyn and all the other consumer advocates and patients involved in our studies. Without whom, this research would not be possible.
1
1
2
A big thank you to @BowtellLab consumer advocate Bronwyn 👏🏻 for sharing her remarkable story of survival from advanced stage ovarian cancer. Check out her story in @theage 👇🏻
Peter Mac Cancer Centre@PeterMacCC4 Dec 2022
From the Sunday Age, research led by @DrDaleGarsed in the @BowtellLab looking into the genomic features of long term #ovariancancer survivors. Read the full story: bit.ly/3UxtzZ9
1
1
18
BowtellLab retweeted
Peter Mac Cancer Centre@PeterMacCC4 Dec 2022
From the Sunday Age, research led by @DrDaleGarsed in the @BowtellLab looking into the genomic features of long term #ovariancancer survivors. Read the full story: bit.ly/3UxtzZ9
4
2
33
Load more